TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,035,000 | +58.0% | 37,564 | -5.4% | 0.00% | +100.0% |
| Q1 2021 | $655,000 | -10.3% | 39,727 | +0.3% | 0.00% | -33.3% |
| Q4 2020 | $730,000 | +31.5% | 39,622 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $555,000 | 0.0% | 40,759 | +31.7% | 0.00% | 0.0% |
| Q2 2020 | $555,000 | +172.1% | 30,950 | +50.9% | 0.00% | +200.0% |
| Q1 2020 | $204,000 | +15.3% | 20,504 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $177,000 | -3.8% | 21,688 | +16.9% | 0.00% | 0.0% |
| Q3 2019 | $184,000 | -22.0% | 18,548 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $236,000 | +22.9% | 18,677 | -0.8% | 0.00% | 0.0% |
| Q1 2019 | $192,000 | +300.0% | 18,836 | +191.8% | 0.00% | – |
| Q4 2018 | $48,000 | -26.2% | 6,455 | -0.8% | 0.00% | – |
| Q3 2018 | $65,000 | – | 6,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |